Publication:
Response #1 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagöz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016

Simple item page
dc.contributor.authorsÇekiç, Osman; Turhan, Semra Akkaya
dc.date.accessioned2022-03-15T11:11:01Z
dc.date.accessioned2026-01-10T17:07:46Z
dc.date.available2022-03-15T11:11:01Z
dc.date.issued2016
dc.identifier.doi10.1089/jop.2016.0030
dc.identifier.issn1557-7732
dc.identifier.pubmedPMID: 27058573
dc.identifier.urihttps://hdl.handle.net/11424/248832
dc.language.isoeng
dc.relation.ispartofJournal of Ocular Pharmacology and Therapeutics: The Official Journal of the Association for Ocular Pharmacology and Therapeutics
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHumans
dc.subjectAnti-Inflammatory Agents
dc.subjectDexamethasone
dc.subjectDrug Implants
dc.subjectIntraocular Pressure
dc.subjectIntravitreal Injections
dc.titleResponse #1 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagöz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016
dc.typearticle
dspace.entity.typePublication
oaire.citation.startPage343
oaire.citation.titleJournal of Ocular Pharmacology and Therapeutics: The Official Journal of the Association for Ocular Pharmacology and Therapeutics
oaire.citation.volume6

Files

Collections

Araştırma Çıktıları